Loading the company…
Loading the company…
In the last ten years FDA made 6 decisions for Proverum (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (5). The latest was on 2026-09-24.
| Family | Decisions on record |
|---|---|
| BPH procedures | 6 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-24 | PMA | P250011-S006 | ProVee System for BPH · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-07-01 | PMA | P250011-S004 | ProVee System for BPH · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-06-15 | PMA | P250011-S003 | ProVee System for BPH · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-06-03 | PMA | P250011-S002 | ProVee System for BPH · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-03-19 | PMA | P250011-S001 | ProVee System for BPH · Labeling Change - Indications/instructions/shelf life/tradename |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Proverum.